Company profile: iSpecimen
1.1 - Company Overview
Company description
- Provider of an online marketplace connecting researchers to millions of human biospecimens and patients across a global network of providers, streamlining specimen procurement. Offers diagnostic remnant, banked, and prospectively collected samples, including biofluids with associated test and clinical data, tissue with clinical/molecular annotation, stem and immune cells with donor attribute options, and matched sets.
Products and services
- Biofluids: Offers various blood and non-blood biofluids accompanied by associated test and clinical data, data-linked, supporting research requiring samples paired with precise clinical and assay information
- ISpecimen Marketplace: Delivers streamlined specimen procurement by enabling access to millions of human biospecimens and patients across a global network of providers, global-scale, consolidating sourcing into a single online platform
- Tissue Samples: Supplies a wide range of disease-state tissue samples, many with clinical and molecular annotation, molecularly annotated, supporting studies requiring annotated tissues across diverse conditions and states
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to iSpecimen
Ion Torrent
HQ: United States
Website
- Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ion Torrent company profile →
Proteos
HQ: United States
Website
- Description: Provider of contract research services specializing in recombinant protein expression and purification to support drug discovery in the biotechnology and pharmaceutical industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proteos company profile →
Miromatrix
HQ: United States
Website
- Description: Provider of fully biological human organs and organ-derived products to address the transplant shortage, using patented perfusion decellularization/recellularization technology, plus PAH therapy and patient support via Remodulin (IV/SC), ASSIST, Archways for inhaled/oral treprostinil, and an Expanded Access Program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miromatrix company profile →
Neothetics
HQ: United States
Website
- Description: Provider of clinical-stage specialty pharmaceutical therapeutics for the aesthetic market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neothetics company profile →
Perfectus Biomed
HQ: United Kingdom
Website
- Description: Provider of U.K.-based microbiological services with a research-driven approach to testing, rapid turnaround, and personalized service, specializing in bespoke assays and biofilm testing. Offers biological safety consulting, clinical research for medical devices, IVD services, product development strategy, quality and regulatory consulting, and the NAMSA APEX Program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perfectus Biomed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for iSpecimen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to iSpecimen
2.2 - Growth funds investing in similar companies to iSpecimen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for iSpecimen
4.2 - Public trading comparable groups for iSpecimen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →